Sangani Hospitals Limited (NSE:SANGANI)
India
· Delayed Price · Currency is INR 45.50
+1.05 (2.36%)
Mar 4, 2026, 3:29 PM IST
Sangani Hospitals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 |
| Operating Revenue | 316.49 | 211.85 | 156.76 | 156.68 | 102.83 | 49.73 | Upgrade
|
| Other Revenue | -0 | - | - | - | 0.12 | 0.09 | Upgrade
|
| Revenue | 316.49 | 211.85 | 156.76 | 156.68 | 102.95 | 49.82 | Upgrade
|
| Revenue Growth (YoY) | 79.04% | 35.14% | 0.05% | 52.19% | 106.64% | 11.59% | Upgrade
|
| Cost of Revenue | 242.52 | 141.26 | 103.87 | 94.42 | 44.94 | 24.28 | Upgrade
|
| Gross Profit | 73.97 | 70.59 | 52.89 | 62.26 | 58.01 | 25.55 | Upgrade
|
| Selling, General & Admin | 6.6 | 6.6 | 0.04 | 0.16 | 1.19 | 0.81 | Upgrade
|
| Other Operating Expenses | 45.05 | 38.94 | 21.37 | 31.19 | 26.09 | 12.66 | Upgrade
|
| Operating Expenses | 59.27 | 51.5 | 24.26 | 42.04 | 28.14 | 14.23 | Upgrade
|
| Operating Income | 14.7 | 19.09 | 28.63 | 20.22 | 29.87 | 11.32 | Upgrade
|
| Interest Expense | - | - | -0.32 | - | -0.43 | -0.77 | Upgrade
|
| Interest & Investment Income | 13.46 | 13.46 | 8.01 | 0.88 | 0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -3.37 | 2.07 | 0.01 | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | 24.78 | 34.62 | 36.33 | 21.1 | 29.45 | 10.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0.63 | - | - | Upgrade
|
| Pretax Income | 24.78 | 34.62 | 36.33 | 20.47 | 29.45 | 10.55 | Upgrade
|
| Income Tax Expense | 5.86 | 8.68 | 9.36 | 5.15 | 7.51 | 2.65 | Upgrade
|
| Earnings From Continuing Operations | 18.92 | 25.94 | 26.97 | 15.32 | 21.94 | 7.9 | Upgrade
|
| Minority Interest in Earnings | -0.06 | -0.01 | - | - | - | - | Upgrade
|
| Net Income | 18.86 | 25.93 | 26.97 | 15.32 | 21.94 | 7.9 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 11.41 | - | Upgrade
|
| Net Income to Common | 18.86 | 25.93 | 26.97 | 15.32 | 10.54 | 7.9 | Upgrade
|
| Net Income Growth | -43.90% | -3.86% | 76.04% | -30.18% | 177.88% | 246.16% | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 12 | 9 | 4 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 12 | 9 | 4 | 2 | Upgrade
|
| Shares Change (YoY) | 10.56% | 11.02% | 31.24% | 139.50% | 133.86% | -7.92% | Upgrade
|
| EPS (Basic) | 1.37 | 1.88 | 2.17 | 1.62 | 2.67 | 4.68 | Upgrade
|
| EPS (Diluted) | 1.37 | 1.88 | 2.17 | 1.62 | 2.67 | 4.68 | Upgrade
|
| EPS Growth | -49.26% | -13.40% | 34.14% | -39.28% | -42.95% | 277.18% | Upgrade
|
| Free Cash Flow | 18.81 | 12.54 | 22.81 | -94.48 | 4.87 | 4.71 | Upgrade
|
| Free Cash Flow Per Share | 1.37 | 0.91 | 1.84 | -9.99 | 1.23 | 2.79 | Upgrade
|
| Gross Margin | 23.37% | 33.32% | 33.74% | 39.74% | 56.35% | 51.27% | Upgrade
|
| Operating Margin | 4.64% | 9.01% | 18.26% | 12.91% | 29.01% | 22.71% | Upgrade
|
| Profit Margin | 5.96% | 12.24% | 17.20% | 9.78% | 10.23% | 15.85% | Upgrade
|
| Free Cash Flow Margin | 5.95% | 5.92% | 14.55% | -60.30% | 4.73% | 9.45% | Upgrade
|
| EBITDA | 20.65 | 25.05 | 31.48 | 30.33 | 30.73 | 12.08 | Upgrade
|
| EBITDA Margin | 6.53% | 11.82% | 20.08% | 19.36% | 29.85% | 24.24% | Upgrade
|
| D&A For EBITDA | 5.96 | 5.96 | 2.85 | 10.11 | 0.86 | 0.76 | Upgrade
|
| EBIT | 14.7 | 19.09 | 28.63 | 20.22 | 29.87 | 11.32 | Upgrade
|
| EBIT Margin | 4.64% | 9.01% | 18.26% | 12.91% | 29.01% | 22.71% | Upgrade
|
| Effective Tax Rate | 23.64% | 25.07% | 25.77% | 25.15% | 25.50% | 25.16% | Upgrade
|
| Revenue as Reported | 327.12 | 227.92 | 165.2 | 157.62 | 102.97 | 49.82 | Upgrade
|
| Advertising Expenses | - | 1.59 | 0.04 | 0.16 | 0.91 | 0.03 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.